i.
Longevity & performance
For patients optimizing healthspan, recovery, and resilience. The most-asked-about area — and the one most polluted by counterfeit clinics. Worth getting right.
Coming 2026
The trusted home for MuseCell therapy in America.
A network built for physicians who take this seriously.
For patients who have done the reading and want a single, credible place to begin. Education, authentication, and access — built around science, operated for patients.
Credentialing a small, founding cohort of physicians for the launch network. Authenticated supply, qualified referrals, peer-developed protocols. Selective by design.
For Patients
Concierge navigation to authentic MuseCell care.
By application. We work with a small number of patients at a time, routing them to credentialed physicians in jurisdictions where therapy is permitted.
Apply for patient navigation
For Clinicians
Founding provider network.
Credentialing physicians and clinic owners with the volume, training, and standards to anchor the launch network.
View clinician track
For Clinicians
Founding provider applications open.
Patient referrals from a national navigation desk. Authenticated MuseCell supply. Territory consideration for founding members.
Request network information
For Patients
If you’re here for treatment, start here.
Patient navigation routes serious inquiries to credentialed providers. Concierge intake. Selective enrollment.
View patient track
A serious option
The patients we serve are already informed.
They have read the studies. They have spoken with their physicians. They know the difference between mesenchymal stem cells, exosomes, and the Muse subpopulation. They have looked abroad and decided they want a domestic, lawful, accountable path.
We exist for that patient. We do not market to people who haven’t done the reading, and we do not promise outcomes. What we offer is access to physicians who meet a standard, supported by a navigation team that does not have a financial reason to push you toward any specific clinic.
The landscape
A category overrun. We were built to fix it.
The problem
Most of what’s marketed as stem cell therapy isn’t.
The category has been overrun. Counterfeit clinics, mislabeled exosome products, and outcomes-promised marketing have made it nearly impossible for a serious patient to know what is real. Most of what is sold under the words “stem cell therapy” is not what those words actually mean.
We were built to fix this. Not with louder marketing — with structure. Verified providers. Authentic product. Care navigation built around what is published, not what is promised.
The approach
MuseCells are different. So is how we make them available.
MuseCells were identified in 2010 by Dr. Mari Dezawa at Tohoku University. They are a small subpopulation of cells already present in the human body — naturally pluripotent, non-tumorigenic, and immune-privileged. The biology is documented across more than 120 peer-reviewed studies, with Phase II trials in stroke, myocardial infarction, ARDS, and ALS.
StemCellSociety is the only U.S. platform built specifically around MuseCell-based therapy. We are not affiliated with every clinic that uses the words. We are connected only to providers we have credentialed.
120+
Peer-reviewed studies on the MuseCell subpopulation
04
Phase II indications: stroke, MI, ARDS, ALS
2010
Identified at Tohoku University by Dr. Mari Dezawa
25
Founding-cohort provider seats — selective by design
Areas of focus
Where the published science is strongest.
ii.
Joint & musculoskeletal
Orthopedic indications where regenerative approaches have the deepest practitioner literature. Routed only to physicians with relevant training.
iii.
Neurological
Where the published Phase II trial data is the most established. Patient candidacy is reviewed individually; nothing on this site is a treatment recommendation.
iv.
Aesthetic medicine
Skin, hair, and dermatologic applications, offered through credentialed practices in jurisdictions where the relevant therapies are permitted.
What we are building
Three things, done deliberately.
Patient education
Webinars, articles, and physician-led explainers covering the science of MuseCells, the available research, and what patients can reasonably learn from a consultation. Not promotional content. Useful content.
Verified provider network
A directory of credentialed clinicians trained on MuseCell protocols. Membership is selective. Standards are visible. No clinic appears on the directory unless it has been vetted for authenticity.
Care navigation
Patient routing to qualified providers in jurisdictions where MuseCell therapy is permitted, regardless of where patients live. Domestic, legal, transparent.
Network membership
What founding providers actually receive.
i. Referrals
Qualified patient flow from a national navigation desk.
We screen for seriousness, geography, and indication before any referral reaches you. Your time is spent on patients who have already been pre-qualified by our team — not on inbound web traffic.
ii. Supply
Authenticated MuseCell product through our supply partnership.
Network membership includes access to authenticated, chain-of-custody product. The supply relationship is the moat. We are connected only to providers who can use it correctly.
iii. Territory
Founding-cohort territory consideration.
Founding members are credentialed before the public directory launches. Geographic exclusivity is considered for the inaugural cohort and will tighten as the network expands.
iv. Standards
Peer-developed protocols and ongoing training.
Protocol training is led by physicians who have done the work. Credentialing is reviewed annually. Membership is contingent on standards, not on tenure.
Founding medical advisors
Built with physicians who’ve already done the work.
Dr. Mari Dezawa
Discoverer, MuseCell · Tohoku University · Scientific advisor
Identified the Muse subpopulation in 2010. Author or co-author on the foundational body of MuseCell literature. Advisory role focused on scientific accuracy of patient and provider materials.
Founding Clinical Chair
U.S. board-certified physician · Announcement: Q3 2026
Leading the protocol committee and credentialing standards for the founding provider cohort. Cohort selection underway with regenerative-medicine and longevity-medicine physicians.
Regulatory Advisor
FDA & state-cell-therapy specialist · Announcement: Q3 2026
Advising on jurisdiction-by-jurisdiction availability of allogeneic cell therapy and the standards by which the directory determines where each member can practice.
Additional founding advisors will be named as their roles are formalized. We do not list names we have not earned.
05 —
Apply for patient navigation
Begin a conversation, not a checkout.
Navigation is concierge and selective. We work with a small number of patients at a time, and we do not enroll everyone who applies. A member of the navigation team will respond personally within five business days.
i.No pricing on this site. No outcome promises.
ii.No financial relationship with any specific clinic.
iii.Only routed where MuseCell therapy is lawfully available.
Thank you. We’ll be in touch when we have something worth sharing.
The navigation team reviews every application personally. Expect a response within five business days.
StemCellSociety is an educational and navigation platform. We do not provide medical advice, diagnose, or treat any condition. All clinical decisions are made by licensed physicians in our authorized network.
05 —
Founding provider inquiry
For physicians and clinic owners.
Credentialing the founding cohort. Membership includes qualified patient referrals, authenticated MuseCell supply, and territory consideration. The standards are high. The opportunity, if you meet them, is real.
i.NPI verification, training review, and credentialing required.
ii.Founding cohort: 25 seats. Selective by design.
iii.Network team responds to qualified inquiries within five business days.
Thank you. We’ll be in touch when we have something worth sharing.
The network team reviews qualified inquiries and will respond within five business days to discuss credentialing and next steps.
Network membership is selective and subject to credentialing. Submitting this form does not guarantee acceptance into the founding cohort.